Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neal Bradsher Insider Profile
4 Followers
Neal Bradsher, Director, Ten Percent Owner at Lineage Cell Therapeutics, holds 13.49M shares in Lineage Cell Therapeutics (Ticker: LCTX), holds 2.06M shares in Questcor (Ticker: QCOR). Most recently, Neal Bradsher Bought ― shares of Lineage Cell Therapeutics on Jul 02, 2014 for an estimated value of 46.00K.
Neal Bradsher Lineage Cell Therapeutics (LCTX)Director, Ten Percent Owner
Lineage Cell Therapeutics (LCTX)
Director, Ten Percent Owner
Ranked #35,943 out of 78,624 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+1.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director, Ten Percent Owner
Roles that Neal Bradsher holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 02, 2014 - Jul 02, 2015
Return:+18.30%
The most profitable trade made by Neal Bradsher
Neal Bradsher's Trading History
Lineage Cell Therapeutics
Jul 02, 2014
Director, Ten Percent Owner
Informative Buy
46.00K
$18.88M
Questcor
May 16, 2014
―
Informative Buy
6.30K
―
List of latest transactions for each holding click on a transaction to see Neal Bradsher's performance on stock
You May Also Like
Neal Bradsher insider profile FAQ
What is the percentage of profitable transactions made by Neal Bradsher?
The percentage of profitable transactions made by Neal Bradsher is 75%.
What is the average return per transaction made by Neal Bradsher?
The average return per transaction made by Neal Bradsher is 1.40%.
What stocks does Neal Bradsher hold?
Neal Bradsher holds: LCTX, QCOR stocks.
What was Neal Bradsher’s latest transaction?
Neal Bradsher latest transaction was an Informative Buy of $46.00K.
What was Neal Bradsher's most profitable transaction?
Neal Bradsher’s most profitable transaction was an Informative Buy of LCTX stock on July 2, 2014. The return on the trade was 18.30%.
What is Neal Bradsher's role in Lineage Cell Therapeutics?
Neal Bradsher's role in Lineage Cell Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.